Respiratory Drug Delivery Formulation Market Outlook, Opportunity and Forecast, 2019-2026

Respiratory Drug Delivery Formulation Market
-
GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Respiratory Drug Delivery Formulation Market – Overview
As per the Global Asthma Network, 2014, asthma affects nearly 334 million people worldwide, thus increase in
prevalence and incidence of respiratory diseases has led to increase in demand for the respiratory drug delivery
formulations. Pharmaceutical manufacturers are focused on increasing access to affordable medications to provide
novel options to patients and pharmacists, thereby addressing the limited availability of respiratory drug delivery
formulations, which in turn is expected to augment market growth. For instance, in August, 2017, Teva
Pharmaceuticals announced that the U.S. FDA approved its QVAR RediHaler inhalation aerosol used for the
maintenance treatment of asthma as a prophylactic therapy in patients aged 4 years and older. Furthermore, in
December 2018, Teva Pharmaceuticals received U.S. FDA approval for its ProAir Digihaler device, a digital
inhaler that uses sensors to connect to mobile app. It is indicated for the treatment of bronchospasm in people with
reversible obstructive airway disease.
Moreover, rising prevalence of various infectious diseases, including respiratory tract infections, is expected to
drive growth of the respiratory drug delivery formulation market in the near future. For instance, according to a
study published in the Lancet Global Health Journal, in 2016, an estimated 55.3 million cases of chronic
obstructive pulmonary disease were observed in India.
REPORT DESCRIPTION
Respiratory Drug Delivery Formulation Market Taxonomy:
On the basis of formulation type:
Solution Aerosol
Suspension Aerosol
On the basis of device type:
Metered Dose Inhaler
Dry Powder Inhaler
On the basis of canister type:
Plain Canister
Coated Canister
On the basis of application:
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Cystic Fibrosis
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2649
REPORT DESCRIPTION
Respiratory Drug Delivery Formulation Market – Key Players
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline
AstraZeneca plc
Merck and Co., Inc
Omron Corporation
Novartis AG
Boehringer Ingelheim GmbH
Sunovion Pharmaceuticals Inc,
Hovione
Catalent Pharma Solutions
Aphios Corporation
Get More Inf @
https://www.coherentmarketinsights.com/ongoing-insight/respiratory-drug-delivery-formulation-market-2649
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
sales@coherentmarketinsights.com
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
sales@coherentmarketinsights.com
+1-206-701-6702

The pulmonary route of drug delivery is most effective in recent times for treatment of respiratory diseases as it enables to target drug delivery directly to lung both for local and systemic treatment.